Published in MMWR Morb Mortal Wkly Rep on May 08, 2009
Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (2009) 8.61
Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Respir Viruses (2009) 2.69
Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis (2011) 2.42
Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. BMJ (2009) 2.42
Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med (2011) 2.41
Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respir Viruses (2009) 2.11
A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis (2010) 2.09
Towards a sane and rational approach to management of Influenza H1N1 2009. Virol J (2009) 2.08
Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol (2009) 1.94
Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology (2010) 1.93
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax (2011) 1.91
Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog (2011) 1.87
A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J Virol (2011) 1.85
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog (2010) 1.81
Pandemic influenza as 21st century urban public health crisis. Emerg Infect Dis (2009) 1.78
Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J Clin Microbiol (2009) 1.76
Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus. Protein Cell (2010) 1.74
Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol (2010) 1.72
Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis). Comp Med (2010) 1.71
Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr (2009) 1.70
Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis (2009) 1.70
Laboratory surge response to pandemic (H1N1) 2009 outbreak, New York City metropolitan area, USA. Emerg Infect Dis (2010) 1.67
Influenza: the once and future pandemic. Public Health Rep (2010) 1.65
Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg Infect Dis (2009) 1.37
Mathematical modeling of the effectiveness of facemasks in reducing the spread of novel influenza A (H1N1). PLoS One (2010) 1.34
Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality. BMC Infect Dis (2010) 1.33
The next public health revolution: public health information fusion and social networks. Am J Public Health (2010) 1.32
Inside the outbreak of the 2009 influenza A (H1N1)v virus in Mexico. PLoS One (2010) 1.30
In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrob Agents Chemother (2010) 1.29
Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS One (2010) 1.28
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice. Antimicrob Agents Chemother (2009) 1.27
Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis (2010) 1.26
The influence of climatic conditions on the transmission dynamics of the 2009 A/H1N1 influenza pandemic in Chile. BMC Infect Dis (2012) 1.22
Public health emergency preparedness and response communications with health care providers: a literature review. BMC Public Health (2011) 1.21
Global alert to avian influenza virus infection: from H5N1 to H7N9. Pathog Glob Health (2013) 1.19
Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One (2010) 1.18
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models. PLoS One (2010) 1.15
Thoracic computerized tomographic (CT) findings in 2009 influenza A (H1N1) virus infection in Isfahan, Iran. J Res Med Sci (2011) 1.15
Case-control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. Emerg Infect Dis (2011) 1.15
The first influenza pandemic of the new millennium. Influenza Other Respir Viruses (2011) 1.14
Reassortment patterns in Swine influenza viruses. PLoS One (2009) 1.13
Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine. Clin Vaccine Immunol (2011) 1.11
Cytokine determinants of viral tropism. Nat Rev Immunol (2009) 1.10
Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets. Virology (2010) 1.10
Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. Mayo Clin Proc (2010) 1.10
A stakeholder-informed approach to the identification of criteria for the prioritization of zoonoses in Canada. PLoS One (2012) 1.07
Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis. PLoS One (2012) 1.06
Pandemic swine influenza virus (H1N1): A threatening evolution. Indian J Microbiol (2010) 1.05
Knowledge and attitudes of university students toward pandemic influenza: a cross-sectional study from Turkey. BMC Public Health (2010) 1.05
Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009. Emerg Infect Dis (2010) 1.05
Epidemiological characteristics of the influenza A(H1N1) 2009 pandemic in the Western Pacific Region. Western Pac Surveill Response J (2010) 1.05
Comparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts. J Virol (2011) 1.05
The effect of age on transmission of 2009 pandemic influenza A (H1N1) in a camp and associated households. Epidemiology (2011) 1.04
Severe coinfections of dengue and pandemic influenza A H1N1 viruses. Pediatr Infect Dis J (2010) 1.03
Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism. J Virol (2011) 1.03
Pathology and viral antigen distribution of lethal pneumonia in domestic cats due to pandemic (H1N1) 2009 influenza A virus. Vet Pathol (2010) 1.03
Pandemic influenza A (H1N1) in Saudi Arabia: description of the first one hundred cases. Ann Saudi Med (2010) 1.02
H1N1-infected Patients in ICU and Their Clinical Outcome. N Am J Med Sci (2012) 1.02
Genetic characterization of human influenza viruses in the pandemic (2009-2010) and post-pandemic (2010-2011) periods in Japan. PLoS One (2012) 1.01
Influenza viral infections among the Iranian Hajj pilgrims returning to Shiraz, Fars province, Iran. Influenza Other Respir Viruses (2012) 1.01
Sentinel surveillance of influenza-like illness in two hospitals in Maracay, Venezuela: 2006-2010. PLoS One (2012) 1.00
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice. Antiviral Res (2012) 1.00
New variants and age shift to high fatality groups contribute to severe successive waves in the 2009 influenza pandemic in Taiwan. PLoS One (2011) 0.99
Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom. Emerg Infect Dis (2011) 0.99
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res (2010) 0.98
Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus. PLoS One (2012) 0.97
Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies. Vaccine (2011) 0.96
Genotyping assay for the identification of 2009-2010 pandemic and seasonal H1N1 influenza virus reassortants. J Virol Methods (2010) 0.95
Hospitalised Malaysian children with pandemic (H1N1) 2009 influenza: clinical characteristics, risk factors for severe disease and comparison with the 2002-2007 seasonal influenza. Singapore Med J (2015) 0.95
Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS One (2011) 0.94
Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strains. J Virol (2012) 0.94
Pandemic (H1N1) 2009 among quarantined close contacts, Beijing, People's Republic of China. Emerg Infect Dis (2011) 0.93
Early detection of pandemic (H1N1) 2009, Bangladesh. Emerg Infect Dis (2012) 0.93
Clinical Outcome of Novel H1N1 (Swine Flu)-Infected Patients During 2009 Pandemic at Tertiary Referral Hospital in Western India. J Glob Infect Dis (2013) 0.92
Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections. Int J Gen Med (2012) 0.92
Swine-origin influenza a outbreak 2009 at Shinshu University, Japan. BMC Public Health (2011) 0.91
Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São Paulo. Clinics (Sao Paulo) (2009) 0.90
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. PLoS One (2011) 0.90
The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One (2013) 0.88
Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS One (2011) 0.88
Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger? Pediatr Nephrol (2010) 0.87
Development and characterization of a highly specific and sensitive SYBR green reverse transcriptase PCR assay for detection of the 2009 pandemic H1N1 influenza virus on the basis of sequence signatures. J Clin Microbiol (2010) 0.87
Molecular imaging reveals a progressive pulmonary inflammation in lower airways in ferrets infected with 2009 H1N1 pandemic influenza virus. PLoS One (2012) 0.87
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity. J Biomed Sci (2010) 0.87
The 'novel' influenza A(H1N1) enigma: is it a pandemic, how should we respond, what should we call it? Influenza Other Respir Viruses (2009) 0.87
Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan. Clin Vaccine Immunol (2011) 0.87
Early outbreak of 2009 influenza A (H1N1) in Mexico prior to identification of pH1N1 virus. PLoS One (2011) 0.86
Pandemic (H1N1) 2009, Shanghai, China. Emerg Infect Dis (2010) 0.86
Risk factors for death from Influenza A(H1N1)pdm09, State of São Paulo, Brazil, 2009. PLoS One (2015) 0.86
Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies. Hum Vaccin Immunother (2014) 0.86
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients. Haematologica (2011) 0.85
Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients. PLoS One (2013) 0.85
Non-specific laboratory test indicators of severity in hospitalized adults with swine influenza (H1N1) pneumonia. Eur J Clin Microbiol Infect Dis (2010) 0.84
Health-care provider preferences for time-sensitive communications from public health agencies. Public Health Rep (2014) 0.84
Risk factors of household transmission of pandemic (H1N1) 2009 among patients treated with antivirals: a prospective study at a primary clinic in Japan. PLoS One (2012) 0.84
Clinical Presentation and Outcome in Hospitalized Patients of 2009 Pandemic Influenza A (H1N1) viral infection in Oman. Oman Med J (2011) 0.84
Hospitalised patients with Influenza A (H1N1) in the Royal Hospital, Oman: Experience of a tertiary care hospital, July-December 2009. Sultan Qaboos Univ Med J (2010) 0.84
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis (2011) 0.84
Reassortment patterns in Swine influenza viruses. PLoS Curr (2009) 0.84
Newly emerging mutations in the matrix genes of the human influenza A(H1N1)pdm09 and A(H3N2) viruses reduce the detection sensitivity of real-time reverse transcription-PCR. J Clin Microbiol (2013) 0.83
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28
Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep (2009) 17.76
Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep (2010) 14.85
Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep (2008) 13.54
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ (2012) 11.57
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep (2009) 11.30
Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ (2014) 11.24
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep (2009) 9.94
Outbreak of West Nile-like viral encephalitis--New York, 1999. MMWR Morb Mortal Wkly Rep (1999) 9.67
Youth risk behavior surveillance - United States, 2009. MMWR Surveill Summ (2010) 9.63
Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003. MMWR Morb Mortal Wkly Rep (2003) 9.37
Youth risk behavior surveillance--United States, 2007. MMWR Surveill Summ (2008) 9.04
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. MMWR Morb Mortal Wkly Rep (2011) 8.80
Ten great public health achievements--United States, 1900-1999. MMWR Morb Mortal Wkly Rep (1999) 8.67
Cigarette smoking among adults--United States, 2004. MMWR Morb Mortal Wkly Rep (2005) 8.60
Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010. MMWR Morb Mortal Wkly Rep (2011) 8.45
Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. MMWR Morb Mortal Wkly Rep (2002) 8.37
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep (2010) 8.16
Cigarette smoking among adults--United States, 2006. MMWR Morb Mortal Wkly Rep (2007) 8.14
Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. MMWR Morb Mortal Wkly Rep (2005) 8.10
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep (2006) 7.90
HIV prevalence estimates--United States, 2006. MMWR Morb Mortal Wkly Rep (2008) 7.76
Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep (2002) 7.34
Cigarette smoking among adults--United States, 2000. MMWR Morb Mortal Wkly Rep (2002) 7.32
Notes from the field: electronic cigarette use among middle and high school students - United States, 2011-2012. MMWR Morb Mortal Wkly Rep (2013) 7.28
HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep (2005) 7.25
Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep (1995) 7.11
Quitting smoking among adults--United States, 2001-2010. MMWR Morb Mortal Wkly Rep (2011) 7.06
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep (2010) 7.04
Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ (2009) 7.02
Vital signs: HIV prevention through care and treatment--United States. MMWR Morb Mortal Wkly Rep (2011) 6.90
Cigarette smoking among adults--United States, 2007. MMWR Morb Mortal Wkly Rep (2008) 6.82
Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009. MMWR Morb Mortal Wkly Rep (2010) 6.72
Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep (1999) 6.57
Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep (2001) 6.49
Prevalence and awareness of HIV infection among men who have sex with men --- 21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep (2010) 6.25
Youth risk behavior surveillance--United States, 2013. MMWR Surveill Summ (2014) 6.17
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 6.09
Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep (2009) 6.08
Tobacco use among middle and high school students - United States, 2011-2014. MMWR Morb Mortal Wkly Rep (2015) 6.05
National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summ (2007) 6.05
Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep (2009) 6.04
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep (2008) 6.02
CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep (2012) 5.77
Cluster of severe acute respiratory syndrome cases among protected health-care workers--Toronto, Canada, April 2003. MMWR Morb Mortal Wkly Rep (2003) 5.50
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48
Trends in the prevalence and incidence of self-reported diabetes mellitus -- United States, 1980-1994. MMWR Morb Mortal Wkly Rep (1997) 5.45
Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. MMWR Surveill Summ (2005) 5.40
Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. MMWR Morb Mortal Wkly Rep (1997) 5.30
Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep (2009) 5.29
Severe acute respiratory syndrome--Singapore, 2003. MMWR Morb Mortal Wkly Rep (2003) 5.28
Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep (2009) 5.25
Tobacco use among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2006) 5.24
Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors--United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Surveill Summ (2006) 5.15
Prevalence of disabilities and associated health conditions among adults--United States, 1999. MMWR Morb Mortal Wkly Rep (2001) 5.14
Current cigarette smoking among adults - United States, 2011. MMWR Morb Mortal Wkly Rep (2012) 5.12
Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep (2009) 5.10
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep (2001) 4.95
Prevalence and most common causes of disability among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2009) 4.86
Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep (2011) 4.85
Nosocomial enterococci resistant to vancomycin--United States, 1989-1993. MMWR Morb Mortal Wkly Rep (1993) 4.77
Surveillance for Lyme disease--United States, 1992-2006. MMWR Surveill Summ (2008) 4.77
Barriers to children walking and biking to school--United States, 1999. MMWR Morb Mortal Wkly Rep (2002) 4.76
Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep (2011) 4.68
Subpopulation estimates from the HIV incidence surveillance system--United States, 2006. MMWR Morb Mortal Wkly Rep (2008) 4.68
Ebola viral disease outbreak--West Africa, 2014. MMWR Morb Mortal Wkly Rep (2014) 4.67
Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 4.64
Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep (2008) 4.64
Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ (2014) 4.53
Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. MMWR Morb Mortal Wkly Rep (2009) 4.50
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep (2009) 4.48
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep (2012) 4.45
Current cigarette smoking among adults - United States, 2005-2012. MMWR Morb Mortal Wkly Rep (2014) 4.39
Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep (2005) 4.39
Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep (2005) 4.36
Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep (2009) 4.36
Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep (2009) 4.36
FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2010) 4.34
HIV surveillance--United States, 1981-2008. MMWR Morb Mortal Wkly Rep (2011) 4.30
Forward: CDC Health Disparities and Inequalities Report - United States, 2011. MMWR Surveill Summ (2011) 4.29
Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. MMWR Morb Mortal Wkly Rep (2010) 4.24
Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. MMWR Recomm Rep (2013) 4.22
National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010. MMWR Morb Mortal Wkly Rep (2011) 4.18
Trends in aging--United States and worldwide. MMWR Morb Mortal Wkly Rep (2003) 4.16
Racial/ethnic disparities in diagnoses of HIV/AIDS--33 states, 2001-2005. MMWR Morb Mortal Wkly Rep (2007) 4.16
Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep (2003) 4.14
Community-based opioid overdose prevention programs providing naloxone - United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 4.13
Ebola virus disease outbreak - Nigeria, July-September 2014. MMWR Morb Mortal Wkly Rep (2014) 4.08
Global youth tobacco surveillance, 2000-2007. MMWR Surveill Summ (2008) 3.98
Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep (2011) 3.98
Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep (2013) 3.96
Update: Outbreak of severe acute respiratory syndrome--worldwide, 2003. MMWR Morb Mortal Wkly Rep (2003) 3.95
Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep (2002) 3.95
Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009. MMWR Morb Mortal Wkly Rep (2011) 3.92
Locally acquired Dengue--Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep (2010) 3.83